BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7099557)

  • 1. An unusual case of ocular involvement in primary systemic nonfamilial amyloidosis.
    Schwartz MF; Green WR; Michels RG; Kincaid MC; Fogle J
    Ophthalmology; 1982 Apr; 89(4):394-401. PubMed ID: 7099557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary nonfamilial amyloidosis of the vitreous. A light microscopic and ultrastructural study.
    Biswas J; Badrinath SS; Rao NA
    Retina; 1992; 12(3):251-3. PubMed ID: 1410835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary familial amyloidosis with vitreous opacities. Report of an autopsy case.
    Ogata J; Okayama M; Goto I; Inomata H; Yoshida I; Omae T
    Acta Neuropathol; 1978 Apr; 42(1):67-70. PubMed ID: 654882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous opacities in primary amyloid disease. A clinical, histochemical, and ultrastructural report.
    Hitchings RA; Tripathi RC
    Br J Ophthalmol; 1976 Jan; 60(1):41-54. PubMed ID: 1268160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary vitreous amyloidosis. Apropos of a case with ultrastructural study].
    Goberville M; Korobelnik JF; D'Hermies F; Cotinat J; Savoldelli M; Chauvaud D; Pouliquen Y
    J Fr Ophtalmol; 1994; 17(6-7):418-22. PubMed ID: 8083492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
    Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
    Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
    Ferreira NN; Cunha Dias DA; Afonso Carvalho RP; Pardal Monteiro Coelho MT
    Retin Cases Brief Rep; 2019 Summer; 13(3):273-278. PubMed ID: 28333852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral amyloidosis of the vitreous body: report of a case without systemic of familial involvement.
    Ferry AP; Lieberman TW
    Arch Ophthalmol; 1976 Jun; 94(6):982-91. PubMed ID: 59590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspiration cytodiagnosis of amyloid from vitreous fluid.
    Gupta RK; Wakefield J; Halliwell T; Foo K; Lallu S; Naran S; Fauck R
    Diagn Cytopathol; 2002 May; 26(5):294-6. PubMed ID: 11992370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonfamilial vitreous amyloidosis diagnosed by portable sutureless vitrectomy.
    Shukla S; Cohen A; Josephberg RG
    Retin Cases Brief Rep; 2008; 2(4):264-5. PubMed ID: 25390585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ocular lesions in primary familial amyloidosis (a syndrome associating opacitieis of the vitreous body, vascular lesions of the retina and an amyloid neuropathy)].
    Franceschetti AT; Rabinowicz T
    J Genet Hum; 1969 Oct; 17(3):349-66. PubMed ID: 4319009
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
    Chen L; Lü L; Zhang P; Li Y; Lin J
    Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare transthyretin mutation (Asp18Glu) associated with vitreous amyloid.
    Solano JM; Pulido JS; Salomao DR
    Ophthalmic Genet; 2007 Jun; 28(2):73-5. PubMed ID: 17558848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical case of the month: non-familial vitreous amyloidosis].
    Tek A; Rakic JM
    Rev Med Liege; 2013; 68(7-8):396-8. PubMed ID: 24053097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical demonstration of prealbumin in the vitreous in heredofamilial amyloidosis.
    Doft BH; Rubinow A; Cohen AS
    Am J Ophthalmol; 1984 Mar; 97(3):296-300. PubMed ID: 6702967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous amyloidosis without systemic or familial involvement.
    Salvador F; Mateo C; Alegre J; Reventos A; García-Arumi J; Corcostegui B
    Int Ophthalmol; 1993-1994; 17(6):355-7. PubMed ID: 8063479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidosis of the vitreous. Fluorescein angiographic findings and association with neovascularization.
    Savage DJ; Mango CA; Streeten BW
    Arch Ophthalmol; 1982 Nov; 100(11):1776-9. PubMed ID: 6182867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular changes in familial amyloidotic polyneuropathy with dense vitreous opacities.
    Monteiro JG; Martins AF; Figueira A; Saraiva MJ; Costa PP
    Eye (Lond); 1991; 5 ( Pt 1)():99-105. PubMed ID: 2060679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
    Roe RH; Fisher Y; Eagle RC; Fine HF; Cunningham ET
    Ophthalmology; 2007 Nov; 114(11):e33-7. PubMed ID: 17980738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.